12/17/24 18:08 | 12/16/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DOT | CEO,P | S.d | -1 | 0.3629 | 0 | -3 | 0 | 7,747 | D | | | | | | | | | | | | | | |
9/17/24 19:21 | 9/16/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DOT | CEO,P | S.d | -1 | 0.6897 | 0 | -2 | 0 | 7,739 | D | | | | | | | | | | | | | | |
6/18/24 21:24 | 6/17/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DOT | CEO,P | S.d | -3 | 1.28 | 0 | -2 | 0 | 7,735 | D | | | | | | | | | | | | | | |
6/6/24 20:35 | 6/4/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Tech | Softw | Prepackaged Software | Mehta Vimal | CT | DOT | CEO,P | S.dm | -405 | 0.2838 | 0 | -1,427 | -16 | 7,731 | I | | | | | | | | | | | | | | |
4/8/24 19:32 | 4/4/24 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.d | -14 | 2.62 | 0 | -5 | 0 | 8,592 | D | | | | | | | | | | | | | | |
6/16/23 18:40 | 6/15/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.dm | -1,252 | 20.86 | 0 | -60 | -59 | 42 | D | | | | | | | | | | | | | | |
5/24/23 16:37 | 5/22/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S | -168 | 25.79 | 0 | -7 | -14 | 39 | D | | | | | | | | | | | | | | |
3/22/23 19:30 | 3/20/23 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P | S.dm | -1,223 | 18.97 | 0 | -65 | -1 | 8,565 | D | | | | | | | | | | | | | | |
12/19/22 20:00 | 12/15/22 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DOT | CEO,P | S.dm | -1,181 | 19.69 | 0 | -60 | -1 | 8,559 | D | | | | | | | | | | | | | | |
6/29/21 17:23 | 6/25/21 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Vimal | CT | DO | CEO,P,Se | S | -14,589 | 30.83 | 0 | -473 | -5 | 8,559 | I | | | | | | | | | | | | | | |